Henrїk Jespersen
@HeManJespersen
Followers
288
Following
2K
Media
43
Statuses
1K
MD PhD. Oncologist at Oslo University Hospital. Medical oncology and cancer research. Mostly melanoma and immunotherapy. Private account. 🇳🇴🇸🇪🇬🇧
Joined April 2009
Having a hard time believing this. Can’t wait to see this scrutinized, and replicated.
Is there a difference in outcomes for patients receiving morning or evening chemoimmunotherapy infusion ? #ASCO25 we have the first randomized trial and its positive!. Several retrospective studies showed that morning immunotherapy infusions are associated with longer survival.
0
0
1
RT @Timothee_MD: Is there a difference in outcomes for patients receiving morning or evening chemoimmunotherapy infusion ? #ASCO25 we have….
0
55
0
RT @ZelenskyyUa: I am grateful to Crown Prince Regent Haakon and Crown Princess Mette-Marit of Norway for the audience. We discussed stren….
0
2K
0
RT @RossellaCrescit: Very proud to present the latest review we wrote about extracellular vesicles in uveal melanoma published in Cancer Le….
0
5
0
RT @JAMAOnc: A modified classification of progressive disease based on PD patterns in patients treated with immune checkpoint inhibitors sh….
0
33
0
RT @Timothee_MD: What is the best 1st line immunotherapy regimen for pts with adv/meta melanoma?. To me, this remains an unsolved Q because….
0
19
0
RT @jitcancer: November @sitcancer #JITC Reading List by Social Media Editor @Praveen_IO selection #4: 15-Gene Expression Profile and PRAME….
0
5
0
RT @Annals_Oncology: 📢New @myESMO guidelines in press - Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and f….
0
25
0
RT @marc_moncrieff: An important piece of work by @SocSurgOnc for clinicians managing #melanoma patients. Bottom line: gene-expression pro….
0
2
0
RT @NobelPrize: BREAKING NEWS.The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Physics to John J. Hopfiel….
0
13K
0
RT @DrJonasANilsson: Happy to share the final version of our @eLife manuscript on tumor-reactive lymphocytes (TRLs) in uveal melanoma.https….
elifesciences.org
Single-cell sequencing and functional analysis identify T cells that can be useful for marker selection and cell therapy in uveal melanoma, a disease largely unresponsive to conventional immune...
0
6
0
RT @OlofssonBagge: @HildurHelg presents out Swedish data showing no OS benefit with adjuvant immunotherapy for stage III melanoma. #ESMO24….
0
5
0
Can we all just agree now that these patients are cured? Time to stop the cautious talk about “long term benefit” and start giving patients with stage IV melanoma real hope. Final survival analysis of CM067 (nivo/ipi+nivo/ipi) in advanced melanoma.
1
1
10
RT @PennMedicine: New research from @PennCancer, published in @Cancer_Cell, challenges fundamental assumptions about how combination #PD1 #….
0
5
0
Begriper ikke at norske myndigheter og folk ikke skjønner dette. Kanskje er den hjemmesmurte matpakka et stolt symbol for måtehold og selvstendighet, men den er også en forsterker av sosial urettferdighet og burde skrotes. @Kunnskapsdep.
0
0
2
RT @pash22: Why free school meals are the hidden bedrock of a better society via @GilesYeo @ajjolley.
sciencefocus.com
The real reasons every school child should be given a healthy, nutritious meal every day.
0
11
0
RT @SyedAAhmad5: Determinants of resistance and response to melanoma therapy @NatureCancer
nature.com
Nature Cancer - Rebecca and colleagues discuss the complex biology of metastatic melanoma, as well as determinants of resistance to therapy and existing and promising therapy strategies.
0
2
0
RT @OncoAlert: Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials out on….
0
52
0
RT @Dr_Ivanoncologo: 🚨 Important results of systemic therapy after recurrence in the CheckMate 238 study in resected #melanoma:. 🔶Recurrenc….
0
7
0